SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076717
Filing Date
2015-11-06
Accepted
2015-11-06 16:31:38
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17791_110q.htm 10-Q 1150469
2 EX-31.1 a15-17791_1ex31d1.htm EX-31.1 10874
3 EX-31.2 a15-17791_1ex31d2.htm EX-31.2 10907
4 EX-32.1 a15-17791_1ex32d1.htm EX-32.1 5963
5 EX-32.2 a15-17791_1ex32d2.htm EX-32.2 5961
  Complete submission text file 0001104659-15-076717.txt   4884408

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtae-20150930.xml EX-101.INS 920948
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtae-20150930.xsd EX-101.SCH 45556
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtae-20150930_cal.xml EX-101.CAL 49142
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vtae-20150930_lab.xml EX-101.LAB 431289
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtae-20150930_pre.xml EX-101.PRE 299384
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtae-20150930_def.xml EX-101.DEF 157927
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36617 | Film No.: 151212347
SIC: 2834 Pharmaceutical Preparations